Limbaugh charged in Florida drug fraud probe
Posted on: Friday, 28 April 2006, 18:49 CDT
MIAMI (Reuters) - Conservative radio commentator Rush Limbaugh turned himself in to police in Florida on Friday and was charged with prescription drug fraud as part of a probe that began more than two years ago, authorities said.
Limbaugh, best known as a brash and often moralistic talk show host, admitted an addiction to prescription painkillers in October 2003 after reports he was facing an investigation for allegedly using a housekeeper to illegally obtain drugs.
He was released on $3,000 bail after being held about one hour at the Palm Beach County Sheriff's Office.
Under a deal disclosed by Limbaugh's attorney, Roy Black, the single count of "doctor shopping" against the radio talk-show host will be dismissed in 18 months.
The charge was that Limbaugh concealed information to fraudulently obtain a prescription drug.
As a primary condition for the dismissal, Limbaugh must continue to seek drug therapy treatment from the doctor who has been treating him for the past 2 1/2 years, Black said in a written statement.
The statement said Limbaugh pleaded not guilty to the charge but agreed to make a $30,000 payment to the state of Florida to defray the public cost of the investigation.
"Mr. Limbaugh had intended to remain in treatment," Black said. "Thus, we believe the outcome for him personally will be much as if he had fought the charge and won."
The investigation came to light in October 2003 while Limbaugh was embroiled in a controversy that forced him to quit his job as a television football commentator.
The controversy stemmed from comments some people saw as racist. Limbaugh said the media wanted Philadelphia Eagles quarterback Donovan McNabb to succeed because he is black.
Source: REUTERS
Related Articles
- Adolor Announces Investigational New Drug Application for Novel Delta Agonist ADL5747
- Depomed Files Investigational New Drug Application for Gabapentin GR for the Treatment of Postmenopausal Hot Flashes
- Bellaire Neurology Conducting Clinical Study of an Investigational Oral Drug for People With Annoying Headaches
- Limbaugh Will Not Be Charged Over Viagra
- Inspire Announces Plans to Begin Phase 2 Testing of Intranasal Epinastine for Seasonal Allergic Rhinitis; Pre-Investigational New Drug Meeting Completed With FDA
- Quigley Pharma Scheduled to Commence Clinical Testing of QR-333, Its Topical Diabetic Peripheral Neuropathy Investigational New Drug; Pharmacokinetics Study at the Diabetes & Glandular Disease Research Center in San Antonio Slated for May 15th Start Date
- Limbaugh OKs Deal, Will Have Drug Tests
- FemmePharma Global Healthcare, Inc. Opens Investigational New Drug Application for Treatment of Breast Pain
- Adolor Corporation Submits Investigational New Drug Application for Novel Delta Opioid Agonist Compound for the Management of Pain
- FDA Approves SIGA's Investigational New Drug Application for Its Smallpox Drug SIGA-246
User Comments (0)

RSS Feeds